Dr Ying K. Tam

Ying K. Tam, Chief Scientific Officer of Acuitas Therapeutics, is a globally recognised expert in nanotechnology and immunology. He directs Acuitas’ scientific strategy and partnerships and has authored more than 100 peer-reviewed studies. He earned his MSc and PhD in developmental and molecular biology from the University of Waterloo and completed a post-doctoral fellowship in cancer immunotherapy at the BC Cancer Agency. He has also held roles in academia, including Assistant Professor at Rush-Presbyterian–St. Luke’s Medical Center in Chicago and Adjunct Professor at the University of British Columbia.